176 related articles for article (PubMed ID: 37887394)
1. Untargeted Metabolomics Reveals Alterations of Rhythmic Pulmonary Metabolism in IPF.
Sun W; Ren J; Jia Z; Liang P; Li S; Song M; Cao Y; Chen H; Luo Q; Yang L; Wang J; Wang C; Wang L
Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887394
[TBL] [Abstract][Full Text] [Related]
2. Disturbance of serum lipid metabolites and potential biomarkers in the Bleomycin model of pulmonary fibrosis in young mice.
Yang XH; Wang FF; Chi XS; Wang XM; Cong JP; Hu Y; Zhang YZ
BMC Pulm Med; 2022 May; 22(1):176. PubMed ID: 35509094
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis.
Du W; Zhang T; Yang F; Gul A; Tang Z; Zhang H; Jiang S; Wang S; Dong J
Phytomedicine; 2022 Aug; 103():154187. PubMed ID: 35667261
[TBL] [Abstract][Full Text] [Related]
4. Research into the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula based on network pharmacology, metabolomics, and verification of AMPK/PPAR-γ pathway of active ingredients.
Yan L; Jiang MY; Fan XS
J Ethnopharmacol; 2023 Dec; 317():116773. PubMed ID: 37308028
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic analysis of fibrotic mice combined with public RNA-Seq human lung data reveal potential diagnostic biomarker candidates for lung fibrosis.
Nojima Y; Takeda Y; Maeda Y; Bamba T; Fukusaki E; Itoh MN; Mizuguchi K; Kumanogoh A
FEBS Open Bio; 2020 Nov; 10(11):2427-2436. PubMed ID: 32961634
[TBL] [Abstract][Full Text] [Related]
6. Lipid metabolism in idiopathic pulmonary fibrosis: From pathogenesis to therapy.
Chen R; Dai J
J Mol Med (Berl); 2023 Aug; 101(8):905-915. PubMed ID: 37289208
[TBL] [Abstract][Full Text] [Related]
7. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
[TBL] [Abstract][Full Text] [Related]
8. Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study.
Zhao YD; Yin L; Archer S; Lu C; Zhao G; Yao Y; Wu L; Hsin M; Waddell TK; Keshavjee S; Granton J; de Perrot M
BMJ Open Respir Res; 2017; 4(1):e000183. PubMed ID: 28883924
[TBL] [Abstract][Full Text] [Related]
9. Establishment of the circadian metabolic phenotype strategy in spontaneously hypertensive rats: a dynamic metabolomics study.
Wang H; Wang X; Qi D; Sun M; Hou Q; Li Y; Jiang H
J Transl Med; 2020 Jan; 18(1):38. PubMed ID: 31992312
[TBL] [Abstract][Full Text] [Related]
10. Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Nambiar S; Tan DBA; Clynick B; Bong SH; Rawlinson C; Gummer J; Corte TJ; Glaspole I; Moodley YP; Trengove R
Proteomics Clin Appl; 2021 May; 15(2-3):e2000039. PubMed ID: 33580915
[TBL] [Abstract][Full Text] [Related]
11. Chloroformate derivatization for tracing the fate of Amino acids in cells and tissues by multiple stable isotope resolved metabolomics (mSIRM).
Yang Y; Fan TW; Lane AN; Higashi RM
Anal Chim Acta; 2017 Jul; 976():63-73. PubMed ID: 28576319
[TBL] [Abstract][Full Text] [Related]
12. Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.
Akram KM; Lomas NJ; Forsyth NR; Spiteri MA
Int J Clin Exp Pathol; 2014; 7(2):552-64. PubMed ID: 24551275
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
bioRxiv; 2022 Jul; ():. PubMed ID: 34873597
[TBL] [Abstract][Full Text] [Related]
14. The arachidonic acid metabolite 11,12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis.
Kim HS; Moon SJ; Lee SE; Hwang GW; Yoo HJ; Song JW
Exp Mol Med; 2021 May; 53(5):864-874. PubMed ID: 33990688
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Profiling Regarding Pathogenesis of Idiopathic Pulmonary Fibrosis.
Kang YP; Lee SB; Lee JM; Kim HM; Hong JY; Lee WJ; Choi CW; Shin HK; Kim DJ; Koh ES; Park CS; Kwon SW; Park SW
J Proteome Res; 2016 May; 15(5):1717-24. PubMed ID: 27052453
[TBL] [Abstract][Full Text] [Related]
16. Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis.
Li JM; Chang WH; Li L; Yang DC; Hsu SW; Kenyon NJ; Chen CH
Respir Res; 2023 May; 24(1):132. PubMed ID: 37194070
[TBL] [Abstract][Full Text] [Related]
17. Dysfunctional lactate metabolism in human alveolar type II cells from idiopathic pulmonary fibrosis lung explant tissue.
Newton DA; Lottes RG; Ryan RM; Spyropoulos DD; Baatz JE
Respir Res; 2021 Oct; 22(1):278. PubMed ID: 34711218
[TBL] [Abstract][Full Text] [Related]
18. Inhibition and role of let-7d in idiopathic pulmonary fibrosis.
Pandit KV; Corcoran D; Yousef H; Yarlagadda M; Tzouvelekis A; Gibson KF; Konishi K; Yousem SA; Singh M; Handley D; Richards T; Selman M; Watkins SC; Pardo A; Ben-Yehudah A; Bouros D; Eickelberg O; Ray P; Benos PV; Kaminski N
Am J Respir Crit Care Med; 2010 Jul; 182(2):220-9. PubMed ID: 20395557
[TBL] [Abstract][Full Text] [Related]
19. Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway.
Yu R; Gao D; Bao J; Sun R; Cui M; Mao Y; Li K; Hu E; Zhai Y; Liu Y; Gao Y; Xiao T; Zhou H; Yang C; Xu J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835236
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
